TMEM68 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.399810E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.372400E-02
Normal-vs-Stage2
1.101190E-03
Normal-vs-Stage3
6.551800E-01
Normal-vs-Stage4
3.651400E-01
Stage1-vs-Stage2
2.069000E-01
Stage1-vs-Stage3
5.038200E-02
Stage1-vs-Stage4
5.207200E-01
Stage2-vs-Stage3
1.562230E-01
Stage2-vs-Stage4
8.965400E-01
Stage3-vs-Stage4
2.704200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.175650E-04
Normal-vs-AfricanAmerican
4.421200E-01
Normal-vs-Asian
1.980420E-01
Caucasian-vs-AfricanAmerican
5.821000E-01
Caucasian-vs-Asian
8.541400E-01
AfricanAmerican-vs-Asian
7.394200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.820100E-04
Normal-vs-Female
2.433300E-04
Male-vs-Female
7.155400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.192000E-01
Normal-vs-Age(41-60Yrs)
4.05829999999829E-05
Normal-vs-Age(61-80Yrs)
3.981800E-04
Normal-vs-Age(81-100Yrs)
2.070800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.704400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.619770E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.349600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.953000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.076400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.333600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.664200E-02
Normal-vs-Daily Drinker
3.240400E-02
Normal-vs-Weekly Drinker
2.383200E-01
Normal-vs-Occasional Drinker
8.392100E-04
Normal-vs-Social Drinker
2.327900E-02
Non Drinker-vs-Daily Drinker
7.312000E-01
Non Drinker-vs-Weekly Drinker
7.704000E-01
Non Drinker-vs-Occasional Drinker
2.072300E-02
Non Drinker-vs-Social Drinker
3.468800E-01
Daily Drinker-vs-Weekly Drinker
5.861800E-01
Daily Drinker-vs-Occasional Drinker
6.543800E-02
Daily Drinker-vs-Social Drinker
5.570600E-01
Weekly Drinker-vs-Occasional Drinker
4.038000E-02
Weekly Drinker-vs-Social Drinker
3.131800E-01
Occasional Drinker-vs-Social Drinker
2.615800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.918620E-01
Normal-vs-Grade 2
1.164050E-02
Normal-vs-Grade 3
1.588010E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.767850E-01
Grade 1-vs-Grade 3
5.494000E-01
Grade 1-vs-Grade 4
1.918620E-01
Grade 2-vs-Grade 3
6.221900E-02
Grade 2-vs-Grade 4
1.164050E-02
Grade 3-vs-Grade 4
1.588010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.882300E-02
Normal-vs-NonDiabetic
4.4712999999974E-05
Diabetic-vs-NonDiabetic
1.776610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.033900E-02
Normal-vs-NoPancreatitis
1.218120E-04
Pancreatitis-vs-NoPancreatitis
9.327800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.298480E-03
Normal-vs-N1
6.231600E-04
N0-vs-N1
2.656600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.36059999994642E-06
Normal-vs-TP53-NonMutant
8.975600E-04
TP53-Mutant-vs-TP53-NonMutant
1.995430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
